Efficacy and Tolerability of Ivabradine for Cardiomyopathy in Patients with Duchenne Muscular Dystrophy-Reference-Cited by-同舟云学术

Efficacy and Tolerability of Ivabradine for Cardiomyopathy in Patients with Duchenne Muscular Dystrophy

Published:2024-03-30 Issue:2 Volume:65 Page:211-217
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Wakisaka Akiko¹,Kimura Koichi²,Morita Hiroyuki³,Nakanishi Koki³,Daimon Masao⁴,Nojima Masanori⁵,Itoh Hideki⁶,Takeda Atsuhito⁷,Kitao Ruriko⁸,Imai Tomihiro⁸,Ikeda Tetsuhiko⁹,Nakajima Takashi⁹,Watanabe Chigusa¹⁰,Furukawa Toshihiro¹¹,Ohno Ichiro¹,Ishida Chiho¹²,Takeda Norihiko³,Komai Kiyonobu¹²

Affiliation:

1. Department of Pediatrics, NHO Iou National Hospital

2. Departments of Laboratory Medicine and Cardiology, The Institute of Medical Science, The University of Tokyo

3. Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo

4. Department of Cardiology, International University of Health and Welfare Mita Hospital

5. Center for Translational Research, The Institute of Medical Science, The University of Tokyo

6. Division of Patient Safety, Hiroshima University Hospital

7. Department of Pediatrics, Hokkaido University

8. Department of Neurology, NHO Hakone Hospital

9. Department of Neurology, NHO Niigata National Hospital

10. Department of Neurology, NHO Hiroshimanishi Medical Center

11. Department of Pediatrics, NHO Hiroshimanishi Medical Center

12. Department of Neurology, NHO Iou National Hospital

Publisher

International Heart Journal (Japanese Heart Journal)

Link

https://www.jstage.jst.go.jp/article/ihj/65/2/65_23-563/_pdf

Reference22 articles.

1. 1. Matthews E, Brassington R, Kuntzer T, Jichi F, Manzur AY. Corticosteroids for the treatment of Duchenne muscular dystrophy. Cochrane Database Syst Rev 2016; 2016: Cd003725.

2. 2. Yusuf S, Pitt B, Davis CE, Hood WB, Cohn JN. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.

3. 3. Bourke JP, Watson G, Muntoni F, et al. Randomised placebo-controlled trial of combination ACE inhibitor and beta-blocker therapy to prevent cardiomyopathy in children with Duchenne muscular dystrophy? (DMD Heart Protection Study): a protocol study. BMJ Open 2018; 8: e022572.

4. 4. Rhodes J, Margossian R, Darras BT, et al. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy. Pediatr Cardiol 2008; 29: 343-51.

5. 5. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13.